Literature DB >> 9816345

The role of surgery in primary hyperthyroidism.

A P Weetman1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9816345      PMCID： PMC1296291          DOI： 10.1177/014107689809133s03

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   5.344


× No keyword cloud information.
  29 in total

1.  Antithyroid drugs and release of inflammatory mediators by complement-attacked thyroid cells.

Authors:  A P Weetman; N Tandon; B P Morgan
Journal:  Lancet       Date:  1992-09-12       Impact factor: 79.321

2.  Cancer mortality after iodine-131 therapy for hyperthyroidism.

Authors:  P Hall; G Berg; G Bjelkengren; J D Boice; U B Ericsson; A Hallquist; M Lidberg; G Lundell; J Tennvall; K Wiklund
Journal:  Int J Cancer       Date:  1992-04-01       Impact factor: 7.396

3.  Current trends in the management of Graves' disease.

Authors:  B Solomon; D Glinoer; R Lagasse; L Wartofsky
Journal:  J Clin Endocrinol Metab       Date:  1990-06       Impact factor: 5.958

Review 4.  Iodine-131 treatment of hyperthyroidism: current issues.

Authors:  J J Farrar; A D Toft
Journal:  Clin Endocrinol (Oxf)       Date:  1991-09       Impact factor: 3.478

5.  Antithyroid drugs and Graves' disease: a prospective randomized evaluation of the efficacy of treatment duration.

Authors:  H Allannic; R Fauchet; J Orgiazzi; A M Madec; B Genetet; Y Lorcy; A M Le Guerrier; C Delambre; V Derennes
Journal:  J Clin Endocrinol Metab       Date:  1990-03       Impact factor: 5.958

6.  Long-term follow-up of treatment of thyrotoxicosis by three different methods.

Authors:  J A Franklyn; J Daykin; Z Drolc; M Farmer; M C Sheppard
Journal:  Clin Endocrinol (Oxf)       Date:  1991-01       Impact factor: 3.478

7.  Cancer risk after iodine-131 therapy for hyperthyroidism.

Authors:  L E Holm; P Hall; K Wiklund; G Lundell; G Berg; G Bjelkengren; E Cederquist; U B Ericsson; A Hallquist; L G Larsson
Journal:  J Natl Cancer Inst       Date:  1991-08-07       Impact factor: 13.506

8.  Radioiodine treatment of recurrent hyperthyroidism in patients previously treated for Graves' disease by subtotal thyroidectomy.

Authors:  H Vestergaard; P Laurberg
Journal:  J Intern Med       Date:  1992-01       Impact factor: 8.989

9.  Occurrence of ophthalmopathy after treatment for Graves' hyperthyroidism. The Thyroid Study Group.

Authors:  L Tallstedt; G Lundell; O Tørring; G Wallin; J G Ljunggren; H Blomgren; A Taube
Journal:  N Engl J Med       Date:  1992-06-25       Impact factor: 91.245

10.  Treatment of hyperthyroidism by radioactive iodine. Summary of a UK national survey prepared for the Royal College of Physicians Committee on Endocrinology and Diabetes.

Authors:  A J Hedley; J H Lazarus; S M McGhee; R B Jones; P F Sharp; L M Naven; C G Beardwell; R Hall
Journal:  J R Coll Physicians Lond       Date:  1992-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.